Filing Details
- Accession Number:
- 0001181431-11-031105
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-19 16:19:49
- Reporting Period:
- 2011-05-17
- Filing Date:
- 2011-05-19
- Accepted Time:
- 2011-05-19 16:19:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1385830 | Neurogesx Inc | NGSX | Pharmaceutical Preparations (2834) | 943307935 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1394522 | K Jeffrey Tobias | C/O Neurogesx, Inc. 2215 Bridgepointe Parkway, Suite 200 San Mateo CA 94404 | Evp Research & Dev & Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-05-17 | 1,333 | $2.73 | 6,114 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-05-18 | 1,115 | $2.82 | 4,999 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares sold ranging from $2.72 to $2.74 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- The sale price reported in column 4 of Table I represents the weighted average sale price of the shares sold ranging from $2.80 to $2.84 per share.
Billionaire Hedge Funds
